MiR-125b regulates endometrial receptivity by targeting MMP26 in women undergoing IVF-ET with elevated progesterone on HCG priming day.
MiR-125b regulates endometrial receptivity by targeting MMP26 in women undergoing IVF-ET with elevated progesterone on HCG priming day.
复制标题
在 HCG 启动日接受 IVF-ET 且黄体酮升高的女性中,MiR-125b 通过靶向 MMP26 来调节子宫内膜容受性
DOI:
10.1038/srep25302
复制
发表时间:
2016-05-04
影响因子:
4.6
通讯作者:
Qiao J
中科院分区:
文献类型:
--
作者:
Chen C;Zhao Y;Yu Y;Li R;Qiao J
On the women undergoing IVF-ET with elevated progesterone on human chorionic gonadotrophin priming, the assisted reproductive technology outcome is poor. But, due to the unknown mechanism of this process, no effective method has been found to overcome this difficulty. Here, we investigated the roles of miR-125b and its target gene, MMP26, in endometrial receptivity (ER) in these women. The expression of miR-125b was significantly up-regulated in EECs in women with elevated progesterone during the window of implantation and it showed a progesterone-dependent effectin vitro. Similarly, the expression of miR-125b was significantly up-regulated in the preimplantation period and was down-regulated in the implantation period and the post-implantation period in mouse EECs. In addition, miR-125b showed a greater decrease at implantation sites than it did at interimplantation sites. The luciferase report assay demonstrated that MMP26 is a target gene of miR-125b. And the expression profile of MMP26 showed an inverse relationship with miR-125bin vivoandin vitro. Overexpression of miR-125b in human EECs inhibited cell migration and invasion. Gain-of-function of miR-125b induced a significant decrease in the number of implantation sites. In conclusion, these data shed new light on how miR-125b triggers ER decline through the regulation of MMP26 function.